Records containing: Metabolic Dysfunction-Associated Steatotic Liver Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-01Evaluation of the Role of Lifestyle Habits in the Presence of Metabolic Dysfunction-associated Steatotic Liver Disease in a Sample of Greek Children and Adolescents
-
CLINICAL_TRIALS study record update · 2025-07-30The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Randomised, Placebo-Controlled, Dietary Intervention Study
-
CLINICAL_TRIALS study record update · 2025-07-17A Prospective Study Evaluating Pegylated Interferon Alpha-2b and Nucleos(t)Ide Analogues in Treating Chronic Hepatitis B With or Without Metabolic Dysfunction-Associated Steatotic Liver Disease
-
CLINICAL_TRIALS study record update · 2025-07-15A Phase 2a Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Different Dosing Regimens of Efinopegdutide (MK-6024) in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease
-
CLINICAL_TRIALS study record update · 2025-06-05Effects of Aerobic or Resistance Exercise, or Both on Intrahepatic Lipid in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease: a Randomized Controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-04Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population: a Cohort Study
-
CLINICAL_TRIALS study record update · 2025-06-03Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia: A Cohort Study With Mediation Analysis
-
CLINICAL_TRIALS study record update · 2025-05-29Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-05-15A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Denifanstat in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MALSD)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
CLINICAL_TRIALS study record update · 2025-04-09Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Pilot Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-03-12Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials
-
CLINICAL_TRIALS study record update · 2025-03-10Metabolic Features Effect on FibroScan-AST (FAST) Score in Egyptian Patients With Metabolic-Associated Steatotic Liver Disease (MASLD)
-
CLINICAL_TRIALS study record update · 2025-03-05Comparison of The Effects of Thiazolidinediones(TZD), Sodium- Glucose Cotransporter 2 Inhibitors(SGLT2i) Alone and TZD / SGLT2i Combination Therapy on Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-02-27Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry: A Retrospective Multicenter Cross-Sectional Study (K-MASLD Registry)
-
CLINICAL_TRIALS study record update · 2025-02-07Prognostic Factors for the Development of Hepatocellular Carcinoma (HCC) and Indications for Liver Transplantation in Patients With Metabolic Liver Diseases (MASLD/MASH): The BOMASH Study
-
CLINICAL_TRIALS study record update · 2024-11-22A Randomized Controlled Trial for Liver Fibrosis Assessment in Diabetic Patients
-
CLINICAL_TRIALS study record update · 2024-08-05Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees